Addex Therapeutics Ltd. (ADXN) Operating Leases (2022 - 2024)

Addex Therapeutics' Operating Leases history spans 3 years, with the latest figure at $39597.1 for Q4 2024.

  • For Q4 2024, Operating Leases fell 89.8% year-over-year to $39597.1; the TTM value through Dec 2024 reached $39597.1, down 89.8%, while the annual FY2024 figure was $39429.9, 89.72% down from the prior year.
  • Operating Leases for Q4 2024 was $39597.1 at Addex Therapeutics, down from $388188.7 in the prior quarter.
  • Across five years, Operating Leases topped out at $388188.7 in Q4 2023 and bottomed at $39597.1 in Q4 2024.
  • The 3-year median for Operating Leases is $387322.3 (2022), against an average of $271702.7.
  • The largest annual shift saw Operating Leases increased 0.22% in 2023 before it crashed 89.8% in 2024.
  • A 3-year view of Operating Leases shows it stood at $387322.3 in 2022, then rose by 0.22% to $388188.7 in 2023, then plummeted by 89.8% to $39597.1 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Operating Leases are $39597.1 (Q4 2024), $388188.7 (Q4 2023), and $387322.3 (Q4 2022).